To investigate how parkin affects cancer cell growth, we transfected NSCLC cells with parkin siRNA using a transfection agent for 48 h, after which analysis of cell growth was performed using the MTT assay. The gene discussed is PRKN; the disease is non-small cell lung carcinoma.